KORU Medical Systems Hits 52-Week Low at $3.21 Amid Market Challenges

KORU Medical Systems, Inc., a microcap player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of USD 3.21 on August 21, 2026. This decline marks a significant point in the company's performance, especially considering its 52-week high was USD 6.61. Over the past year, KORU Medical has experienced a return of -21.90%, contrasting sharply with the S&P 500's performance of 20.47%. Despite this downturn, the company has reported positive results for the last eight consecutive quarters, with a notable operating cash flow of USD 0.71 million and a net profit of USD -1.29 million for the half-year period. The company’s market capitalization stands at USD 210 million, and it has a negative return on equity of -15.47%. Additionally, KORU Medical's debt-to-equity ratio is -0.49, indicating a unique financial structure. Institutional holdings are relatively high at 54.92%, reflecting a significant interest from larger investors who may have the resources to analyze the company's fundamentals more thoroughly.